Anti-KMT6 / EZH2 antibody [SP129]
- RabMAb
- Advanced Validation
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal KMT6 / EZH2 antibody. C-terminal. Suitable for ChIC/CUT&RUN-seq, IP, Flow Cyt (Intra), WB, IHC-P and reacts with Human, Mouse samples. Cited in 5 publications.
View Alternative Names
KMT6, EZH2, Histone-lysine N-methyltransferase EZH2, ENX-1, Enhancer of zeste homolog 2, Lysine N-methyltransferase 6
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KMT6 / EZH2 antibody [SP129] (AB227648)
Formalin-fixed paraffin-embedded human prostate cancer tissue stained for KMT6 / EZH2 using ab227648 at 1/100 dilution in immunohistochemical analysis.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-KMT6 / EZH2 antibody [SP129] (AB227648)
Flow cytometric analysis of HeLa (human epithelial cell line from cervix adenocarcinoma) cell line labeling KMT6 / EZH2 with ab227648 at 1/100 dilution (green) compared with a negative control of rabbit IgG (blue).
- WB
Lab
Western blot - Anti-KMT6 / EZH2 antibody [SP129] (AB227648)
Blocking/Diluting buffer and concentration : 5% NFDM /TBST
All lanes:
Western blot - Anti-KMT6 / EZH2 antibody [SP129] (ab227648) at 0.316 µg/mL
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) cell lysate at 20 µg
Lane 2:
NIH/3T3 (Mouse embryonic fibroblast) cell lysate at 20 µg
Lane 3:
Mouse brain tissue lysate at 20 µg
Lane 4:
HEK-293 (Human embryonic kidney epithelial cell) cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 0.05 µg/mL
Predicted band size: 85 kDa
Observed band size: 85 kDa
false
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-KMT6 / EZH2 antibody [SP129] (AB227648)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2 x 10^5 K-562 (Human chronic myelogenous leukemia lymphoblast) cells and 5 µg of ab227648 [SP129]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- IP
Lab
Immunoprecipitation - Anti-KMT6 / EZH2 antibody [SP129] (AB227648)
ab227648 (purified) at 1/20 dilution (20 μg/ml) immunoprecipitating KMT6 in HEK-293 whole cell lysate.
Lane 1 (input) : HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab227648 & HEK-293 whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab227648 in HEK-293 whole cell lysate
For western blotting, ab227648 (purified at 1/500 dilution (0.632 μg/ml) and veriBlot for IP secondary antibody (HRP) (ab131366) at 1/1000 dilution were used.
Blocking and diluting buffer : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-KMT6 / EZH2 antibody [SP129] (ab227648)
Predicted band size: 85 kDa
false
- WB
Supplier Data
Western blot - Anti-KMT6 / EZH2 antibody [SP129] (AB227648)
All lanes:
Western blot - Anti-KMT6 / EZH2 antibody [SP129] (ab227648) at 1/25 dilution
All lanes:
HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate
Predicted band size: 20 kDa,85 kDa
Observed band size: 22 kDa
false
Related conjugates and formulations (8)
-
Anti-KMT6 / EZH2 antibody [SP129] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-KMT6 / EZH2 antibody [SP129]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-KMT6 / EZH2 antibody [SP129]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-KMT6 / EZH2 antibody [SP129]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-KMT6 / EZH2 antibody [SP129]
-
578 PE
PE Anti-KMT6 / EZH2 antibody [SP129]
-
660 APC
APC Anti-KMT6 / EZH2 antibody [SP129]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-KMT6 / EZH2 antibody [SP129]
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EZH2 plays a central role in regulating gene expression during development and differentiation. It is a core component of the PRC2 complex which includes other proteins such as EED and SUZ12. Through its catalytic activity EZH2 contributes to the maintenance of the transcriptionally repressed state of genes influencing processes such as cell identity and proliferation. In many cell types EZH2-mediated gene silencing is necessary for normal development and dysregulation can lead to aberrant cellular processes.
Pathways
EZH2 participates in key regulatory networks notably the Wnt signaling pathway and the p53 pathway. Within the Wnt pathway EZH2's activity contributes to controlling gene expression that influences cellular differentiation and proliferation. Meanwhile interaction with the p53 pathway can impact the cellular response to stress and DNA damage highlighting EZH2’s regulatory dimension. Other proteins like β-catenin in the Wnt pathway interact with EZH2 reflecting its integration in these complex signaling networks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 13:657 PubMed35902569
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 25:116-126 PubMed34401209
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 12:188 PubMed33589600
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 24:11858-11873 PubMed32885590
2020
Applications
Unspecified application
Species
Unspecified reactive species
Urologic oncology 36:343.e1-343.e8 PubMed29748098
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com